Aclarion, Inc.
About Aclarion, Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $75.7K
- Net income
- -$7.2M
- Total assets
- $13.7M
- Market cap
- $8.8M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $8.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 22, 2022
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Aclarion, Inc..